GGrantIndex
Sort

1,049,261 grants matching t cell

The Role of Chemical Exposures in Alzheimer's Disease (AD) and its Trajectory

$2,499,382
Rima F Kaddurah-Daouk · Duke University · U01 · FY2024 · AG

Apolipoprotein E genotype modulates brain mitovesicle production, a component of mitochondrial quality control

$2,499,343
Efrat Levy · Nathan S. Kline Institute For Psych Res · RF1 · FY2024 · AG

Alzheimer's Disease Research Center

$2,499,318
John Morris · Washington University · P50 · FY2007 · AG

Continuation of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study

$2,499,231
John M Lachin · George Washington University · U01 · FY2017 · DK

CHEMISTRY AND BIOLOGY OF HUMAN LYMPHOCYTES

$2,499,147
Harvard University · R35 · FY2000 · CA

Project 3: Delineating and Drugging the Core Transcriptional Circuitry in Ewing Sarcoma

$2,499,136
Kimberly Stegmaier · Dana-Farber Cancer Inst · U54 · FY2018 · CA

Conte Centers for the Neuroscience of Depression

$2,499,049
Duke University · P50 · FY2005 · MH

Understanding the Origins of Early COPD

$2,499,040
Fernando J Martinez · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · HL

Interrogating the molecular underpinnings of metastatic colonization

$2,498,874
Jonathan Hernandez · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Integrative Oncogenomics of Multiple Myeloma

$2,498,796
Nikhil C. Munshi · Dana-Farber Cancer Inst · P01 · FY2023 · CA

Autism Genetics, Phase II: Increasing Representation of Human Diversity

$2,498,781
Daniel H Geschwind · University Of California Los Angeles · R01 · FY2016 · MH

A Novel Blood Substitution Approach Treats Acute Ischemia in the Aged Brain

$2,498,714
Xuefang Sophie Ren · University Of Texas Hlth Sci Ctr Houston · RF1 · FY2025 · AG

Targeted Therapies in Melanoma

$2,498,687
Meenhard Herlyn · Wistar Institute · P01 · FY2020 · CA

Cellular Basis of Immunological and Neurological Disease

$2,498,625
University Of Hawaii At Manoa · P20 · FY2005 · RR

Interdisciplinary research in vascular biology

$2,498,582
Rodger Paul McEver · Oklahoma Medical Research Foundation · P20 · FY2014 · GM

Point-of care Microfluidics for Early Detection of Cancer

$2,498,556
Mehmet Toner · Massachusetts General Hospital · U01 · FY2010 · EB

Brain Tumor SPORE Grant

$2,498,496
Mitchel S. Berger · University Of California, San Francisco · P50 · FY2018 · CA

A vaccine design to induce protective B and T cell immunity against hepatitis C virus

$2,498,468
Steven Foung · Stanford University · U19 · FY2022 · AI

Targeted Therapies in Melanoma

$2,498,463
Meenhard Herlyn · Wistar Institute · P01 · FY2017 · CA

Arabidopsis 2010: Functional Genomics of NBS-LRR Mediated Resistance

$2,498,405
Richard W Michelmore · University Of California-Davis · · FY2009 · BIO

PATHOPHYSIOLOGY OF THE ENDOTHELIUM

$2,498,374
Michael A Gimbrone · Brigham And Women'S Hospital · P01 · FY2007 · HL

Broad Institute Mendelian Genomic Research Center

$2,498,225
Anne O'Donnell-Luria · Broad Institute, Inc. · U01 · FY2023 · HG

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH

$2,498,155
Robert Stanley Sherwin · Yale University · UL1 · FY2010 · RR

MOLECULAR/CLINICAL APPROACHES TO COLON CANCER PRECURSORS

$2,497,978
Randall Walter Burt · University Of Utah · P01 · FY2006 · CA

Illuminating Druggable Dark Matter

$2,497,882
Michael T McManus · University Of California, San Francisco · U24 · FY2020 · DK